151 related articles for article (PubMed ID: 20075511)
1. Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease.
Shakoori TA; Sin DD; Ghafoor F; Bashir S; Bokhari SN
Dis Markers; 2009; 27(6):287-94. PubMed ID: 20075511
[TBL] [Abstract][Full Text] [Related]
2. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
[TBL] [Abstract][Full Text] [Related]
3. The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease.
Zien Alaabden A; Mohammad Y; Fahoum S
Qatar Med J; 2015; 2015(2):18. PubMed ID: 26942111
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
6. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.
Lomas DA; Silverman EK; Edwards LD; Locantore NW; Miller BE; Horstman DH; Tal-Singer R;
Eur Respir J; 2009 Jul; 34(1):95-102. PubMed ID: 19164344
[TBL] [Abstract][Full Text] [Related]
7. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease.
Ju CR; Liu W; Chen RC
Dis Markers; 2012; 32(5):281-7. PubMed ID: 22674408
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation.
Obeidat M; Li X; Burgess S; Zhou G; Fishbane N; Hansel NN; Bossé Y; Joubert P; Hao K; Nickle DC; van den Berge M; Timens W; Cho MH; Hobbs BD; de Jong K; Boezen M; Hung RJ; Rafaels N; Mathias R; Ruczinski I; Beaty TH; Barnes KC; Paré PD; Sin DD;
Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29191953
[TBL] [Abstract][Full Text] [Related]
9. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study.
Sin DD; Leung R; Gan WQ; Man SP
BMC Pulm Med; 2007 Oct; 7():13. PubMed ID: 17922919
[TBL] [Abstract][Full Text] [Related]
10. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
Kobayashi H; Kanoh S; Motoyoshi K
Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
[TBL] [Abstract][Full Text] [Related]
11. Serum Surfactant Protein D is a Potential Biomarker for Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis.
Wang H; Li F; Huang H; Wu F; Chen L; Zhang D; Zhang T; Wan Y
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850711
[TBL] [Abstract][Full Text] [Related]
12. Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease.
Ito E; Oka R; Ishii T; Korekane H; Kurimoto A; Kizuka Y; Kitazume S; Ariki S; Takahashi M; Kuroki Y; Kida K; Taniguchi N
J Proteomics; 2015 Sep; 127(Pt B):386-94. PubMed ID: 26206179
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of serum surfactant protein D (SP-D) levels as a biomarker of lung injury in tuberculosis and different lung diseases.
Güzel A; Karadağ A; Okuyucu A; Alaçam H; Küçük Y
Clin Lab; 2014; 60(7):1091-8. PubMed ID: 25134376
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.
Ou CY; Chen CZ; Hsiue TR; Lin SH; Wang JY
Respirology; 2015 Feb; 20(2):296-303. PubMed ID: 25376584
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD.
Duvoix A; Miranda E; Perez J; Sorensen GL; Holmskov U; Trapnell BC; Madsen J; Clark HW; Edwards LD; Miller BE; Tal-Singer RM; Lomas DA
COPD; 2011 Apr; 8(2):79-95. PubMed ID: 21495836
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein D as a marker for pulmonary complications in pediatric patients with sickle cell disease: Relation to lung function tests.
Tantawy AA; Adly AA; Ebeid FSE; Ismail EA; Hussein MM; Shaarawy RM; Kamel RA
Pediatr Pulmonol; 2019 May; 54(5):610-619. PubMed ID: 30672154
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
18. Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.
Bowler RP
COPD; 2012 Dec; 9(6):651-3. PubMed ID: 23244171
[TBL] [Abstract][Full Text] [Related]
19. SP-D polymorphisms and the risk of COPD.
Shakoori TA; Sin DD; Bokhari SN; Ghafoor F; Shakoori AR
Dis Markers; 2012; 33(2):91-100. PubMed ID: 22846212
[TBL] [Abstract][Full Text] [Related]
20. Association of Serum Vitamin D (25OHD) Level with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Islam S; Sarkar NK; Mujahid AA; Bennoor KS; Hossain SS; Attar MM; Jahan R; Hossain MA; Chowdhury HA; Ali L
Mymensingh Med J; 2019 Apr; 28(2):441-448. PubMed ID: 31086164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
